We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current RVV market cap is 28.61M. The company's latest EPS is CAD -0.0177 and P/E is -4.52.
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -1.35M | -2.47M | -16.19M | -16.53M | -4.97M |
Net Income | -1.34M | -5.38M | -20.12M | -17.81M | -6.32M |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 1.28M | 8.26M | 29.81M | 17.07M | 14.25M |
Total Liabilities | 322k | 831k | 999k | 4.46M | 3.6M |
Total Equity | 960k | 7.43M | 28.81M | 12.6M | 10.65M |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -1.18M | -2.52M | -8.31M | -13.06M | -6.03M |
Investing | -751k | 142k | -2.72M | N/A | N/A |
Financing | 1.35M | 3.28M | 26.25M | 376k | 4.2M |
Market Cap | 28.61M |
Price to Earnings Ratio | -4.52 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 13.79 |
Price to Book Ratio | 2.69 |
Dividend Yield | - |
Shares Outstanding | 357.65M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.01 (11.76%) |
Company Name | Revive Therapeutics Ltd |
Address |
82 richmond street east toronto, ontario M5C 1P1 |
Website | https://www.revivethera.com |
Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions